Can a weight-loss injection truly safeguard your vision? :eyes:
A significant study conducted in the US involving more than 170,000 patients indicates that Mounjaro, or tirzepatide, might greatly reduce the likelihood of developing diabetic retinopathy — a severe eye ailment that can result in blindness.
With over 25% of individuals with diabetes experiencing retinal damage, this discovery could transform lives. This is particularly important in light of recent alerts connecting other weight-loss medications such as semaglutide, found in Wegovy and Ozempic, to rare instances of vision impairment.
Could this represent the future of diabetes management? Tune in now to learn how this injection might help shield millions from losing their sight.
Comments